Stay updated on Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error where the study record content was shown. This indicates access to the content is blocked, representing a non-substantive access issue rather than a content update.
    Difference
    21%
    Check dated 2026-09-22T22:59:01.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.6 to v3.7.0, indicating a refresh of the page metadata rather than a modification to study details.
    Difference
    0.1%
    Check dated 2026-09-15T21:36:40.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a minor internal update. There are no changes to the visible content or functionality presented on the study page.
    Difference
    0.1%
    Check dated 2026-09-01T18:10:39.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects a minor update to the page's revision tag rather than a change to study data or content.
    Difference
    0.0%
    Check dated 2026-08-11T15:52:30.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4. This signals a backend/documentation update without changing the displayed study details.
    Difference
    0.0%
    Check dated 2026-07-28T05:10:07.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.3, signifying a small documentation/versioning update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-07-06T10:57:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.